Methimazole blocks Graves' IgG but not interferon-gamma HLA-DR expression by thyroid cells.
We have expanded our early observation that a potent Graves' IgG preparation induces HLA-DR expression on thyroid cells, by showing that four randomly-selected Graves' IgG's were also capable of inducing DR antigens on thyroid cells. The effect of Graves' IgG was specific to thyroid cells, as it did not induce MHC Class II molecule expression on endothelial cells whereas interferon-gamma and immune complexes did so. The anti-thyroid drug methimazole was capable of rapidly reducing Graves' IgG-induced DR expression but to a much lesser extent than brought about by interferon-gamma. We conclude that Graves' IgG propagates thyroid-specific autoaggression by continued induction of DR antigens and than an important means whereby methimazole brings about remission is by reducing this induction.
D006111:Graves Disease / Q000188:drug therapy / Q000276:immunology*; D006684:HLA-DR Antigens; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000494:pharmacology; D008713:Methimazole / Q000494:pharmacology*; D013961:Thyroid Gland / Q000187:drug effects / Q000276:immunology
D006684:HLA-DR Antigens; D007074:Immunoglobulin G; D008713:Methimazole; D007371:Interferon-gamma